AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer

To improve ovarian cancer patient survival, effective treatments addressing chemoresistant recurrences are particularly needed. Mullerian inhibiting substance (MIS) has been shown to inhibit the growth of a stem-like population of ovarian cancer cells. We have recently engineered peptide modificatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proc Natl Acad Sci U S A
Hauptverfasser: Pépin, David, Sosulski, Amanda, Zhang, Lihua, Wang, Dan, Vathipadiekal, Vinod, Hendren, Katherine, Coletti, Caroline M., Yu, Aaron, Castro, Cesar M., Birrer, Michael J., Gao, Guangping, Donahoe, Patricia K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: National Academy of Sciences 2015
Schlagworte:
PNAS Plus
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538667/
https://ncbi.nlm.nih.gov/pubmed/26216943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1510604112
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge